Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Winkenwerder Strategies is a healthcare-focused strategic advisory and consulting firm led by Dr. William Winkenwerder Jr. The firm provides expert guidance to healthcare organizations, private equity firms, and government entities on matters involving health policy, business strategy, and operational improvement. Leveraging Dr. Winkenwerder's extensive experience as a former CEO of Highmark and Assistant Secretary of Defense for Health Affairs, the company assists clients in navigating complex regulatory environments and market transitions. Their services encompass market entry strategies, health information technology implementation, and clinical quality enhancement. The firm is particularly noted for its expertise in federal health programs and large-scale healthcare system management. Winkenwerder Strategies operates as a boutique consultancy, offering high-level executive insights to drive growth and efficiency in the healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Winkenwerder Strategies.